Corporate Investor

Updated:

Bayer Vital

Bayer Vital is a corporate investor based in Leverkusen, Germany. It manages approximately $72 billion in assets across four funds, primarily focused on...

Bayer Vital logo

Bayer Vital

Bayer Vital is a corporate investor based in Leverkusen, Germany. It manages approximately $72 billion in assets across four funds, primarily focused on European investments.

General information

Firm type

Corporate Investor

Year founded

AUM

Undisclosed

Location

Region

Europe

Country

Germany

City

Leverkusen

Corporate office

Kaiser-Wilhelm-Allee, 51368 Leverkusen, Germany

Additional offices

Rogers, AR, USA

Principals

Christian Lauterbach

Managing Director

Barbara Stollfuss

Head of Medical Affairs Digital Strategy & Transformation

Frequently asked questions

Who runs investment decisions at Bayer Vital?

Christian Lauterbach serves as Managing Director. Barbara Stollfuss holds the position of Head of Medical Affairs Digital Strategy & Transformation.

How is Bayer Vital related to Bayer AG?

Bayer AG owns 100% of Bayer Vital GmbH.

Does Bayer Vital maintain philanthropic structures?

Two foundations are listed: Bayer Cares Foundation and Bayer Science & Education Foundation.

Where does Bayer Vital maintain offices?

Headquarters sit at Kaiser-Wilhelm-Allee in Leverkusen, Germany. An additional office operates in Rogers, Arkansas.

Which industry associations does Bayer Vital belong to?

The firm belongs to VFA, BPI and BAH.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Leverkusen Corporate Investor profiles